SIGA to Present at the 14th Annual Wells Fargo Securities Healthcare Conference on September 5, 2019
28 août 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Awarded Department of Defense Contract to Develop Expanded Indication for TPOXX® as Post-Exposure Prophylactic for Smallpox
08 juil. 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA Technologies CEO to Speak at NCT Europe on June 27, 2019
18 juin 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Technologies to Host Business Update Webcast on June 18, 2019
11 juin 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, June 11, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...
SIGA Announces TPOXX® Promotion Agreement with Meridian Medical Technologies, Inc. (A Pfizer Company) for International Markets
03 juin 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA Announces Exercise of Option for the Purchase of Raw Materials for Oral TPOXX® Manufacturing Totaling $11 Million
20 mai 2019 16h30 HE
|
SIGA Technologies Inc.
Raw Materials expected to be used to Support Manufacture of 363,070 Courses of Oral TPOXX NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a...
SIGA to Present at the 8th Annual SVB Leerink Global Healthcare Conference on March 1, 2019
21 févr. 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Announces Priority Review Voucher Transaction Totaling $80 Million
01 nov. 2018 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA Enters into Cooperative Research and Development Agreement with U.S. Army Medical Research Institute of Infectious Disease to Evaluate the Efficacy of TPOXX® as a Post-Exposure Prophylactic for Smallpox
04 oct. 2018 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Oct. 04, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 2, 2018
27 sept. 2018 07h30 HE
|
SIGA Technologies Inc.
- Company Hosting Business Update Webcast Today at 4:30pm ET - NEW YORK, Sept. 27, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company...